Euclidean Capital LLC Portfolio Holdings

Euclidean Capital LLC

  • $906 Million
  • Q3 2024

Euclidean Capital LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $906 Million distributed in 12 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Spdr S&P 500 ETF Trust with a value of $690M, Ishares Msci India Index Fund with a value of $142M, Vanguard Ftse All World Ex Us with a value of $32M, Foghorn Therapeutics Inc. with a value of $14.7M, and Oric Pharmaceuticals, Inc. with a value of $10.1M.

Examining the 13F form we can see an increase of $111M in the current position value, from $795M to 906M.

Euclidean Capital LLC is based out at New York, NY

Below you can find more details about Euclidean Capital LLC portfolio as well as his latest detailed transactions.

Portfolio value $906 Million
ETFs: $864 Million
Healthcare: $41.7 Million

Stock Holdings Table Market Cap. of $300 Millions to $2 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$325M
$10.1 Million 1.12% of portfolio
989,410
Q3 2023 Added 32.35%
$849M
$3.59 Million 0.4% of portfolio
10,243,122
Q1 2022 Added 0.0%

Summary

  • Portfolio
  • No. of Stocks 12
  • Current Value $906 Million
  • Prior Value $795 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 1 stocks
  • Additional Purchases 1 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Euclidean Capital LLC Portfolio

Follow Euclidean Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Euclidean Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Euclidean Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email